GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apellis Pharmaceuticals Inc (FRA:1JK) » Definitions » Float Percentage Of Total Shares Outstanding

Apellis Pharmaceuticals (FRA:1JK) Float Percentage Of Total Shares Outstanding : 72.35% (As of May. 22, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Apellis Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Apellis Pharmaceuticals's float shares is 87.81 Mil. Apellis Pharmaceuticals's total shares outstanding is 121.37 Mil. Apellis Pharmaceuticals's float percentage of total shares outstanding is 72.35%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Apellis Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Apellis Pharmaceuticals's Institutional Ownership is 53.71%.

Apellis Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Apellis Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=87.81/121.37
=72.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apellis Pharmaceuticals (FRA:1JK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apellis Pharmaceuticals Inc (FRA:1JK) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
KRTX ABCZF IONS ASND EXEL IMVT ROIV HALO PCVX BBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
APLS:USA
Address
100 Fifth Avenue, Waltham, MA, USA, 02451
Website
https://www.apellis.com
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.

Apellis Pharmaceuticals (FRA:1JK) Headlines

No Headlines